Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Intravenous immunoglobulin therapy for ocular cicatricial pemphigoid: a preliminary study.

Intravenous immunoglobulin therapy for ocular cicatricial pemphigoid: a preliminary study. Ophthalmology. 1999 Nov; 106(11):2136-43.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.